Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Intermediate to dopamine-.beta.-hydroxylase inhibitors

Intermediate to dopamine-.beta.-hydroxylase inhibitors

US Patent 4912226 · Granted Mar 27, 1990

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or ty2021
Compositions and methods of using modified release solabegron for lower urinary 2020
Pharmaceutical compositions and the treatment of overactive bladder2020
Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or ty2019
Pharmaceutical compositions and the treatment of overactive bladder2019
Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, o2018
Compositions and methods of using modified release solabegron for lower urinary 2018
Pharmaceutical compositions and the treatment of overactive bladder2018
Pharmaceutical Combination2016
Use of a PPAR-delta agonist for treating muscle atrophy2016
Pharmaceutical combinations of beta-3 adrenergic receptor agonists and muscarini2014
Small organic molecule regulators of cell proliferation2012